Recall: Teva- Bupropion 300mg - lower strength tablet

Product quality

Date

2024-08-09

Country

Canada

Product

TEVA-BUPROPION XL 300MG TABLETS

Classification

Type II

Category

Drugs & medical

Source

Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

1. 2024-08-14
2. CA
   Drugs & medicalType II

   StealthStation S8 Application

   Performance

   Health CanadaOfficial notice →
3. 2024-08-13
4. CA
   Drugs & medicalType I

   ACH-SITAGLIPTIN: May exceed established acceptable intake limit for NTTP.

   Product safety

   Health CanadaOfficial notice →
5. 2024-08-12
6. CA
   Drugs & medicalType I

   Vercise Genus ™ R16 and R32 Implantable Pulse Generator (IPG) Kits

   Performance

   Health CanadaOfficial notice →
7. 2024-08-07
8. CA
   Drugs & medicalType II

   Recall: JAMP Rabeprazole 10mg Over-sized delayed release tablets

   Product quality

   Health CanadaOfficial notice →
9. 2024-08-06
10. CA
    Drugs & medicalType I

    JAMP DIGOXIN: Affected lot may contain overweight or underweight tablets.

    Product safety

    Health CanadaOfficial notice →
11. 2024-08-05
12. CA
    Drugs & medicalType I

    Expanded recall: ratio-ECTOSONE (TEVA-ECTOSONE) 0.1% regular lotion and 0.05% mild lotion recalled due to an impurity that may pose health risks

    Product quality - Labelling

    Health CanadaOfficial notice →